VitaHEAT Medical, a privately held medical device company, announced the launch of the VitaHEAT UB3 patient warming system.
VitaHEAT UB3 is a breakthrough innovation in under-body patient warming, using patented conductive ink technology in a thin mattress design. VitaHEAT UB3 is safe and effective, easy to use and cost efficient. It is always on and can be used throughout all perioperative phases.
The VitaHEAT UB3 is easy to set up and operate. The thin mattress is virtually invisible to clinicians and allows full access to surgical sites. It is flexible, easy to clean and completely portable. It is the only system on the market with both battery and plug-in AC options. VitaHEAT UB3 is also more cost efficient than forced-air systems. It is reusable and eco-friendly, with no disposables or red bag waste costs.
Hypothermia in patients is common during and after surgery. The incidence of hypothermia ranges from 60% to 85% in all postoperative patients when active warming is not used. The average postoperative hypothermia patient can cost the hospital up to $7,000, and has an extended length of stay by 2.6 days, on average. Mortality rates jump to 31% and wound infection rates jump to 19% when a patient becomes hypothermic.
In a recent clinical study, 94% of patients following 30 minutes of preoperative warming maintained normothermia, or a normal body temperature. Intraoperative patient warming reduces costs, recovery time and post-anesthesia care unit (PACU) stay.
VitaHEAT UB3 meets all FDA safety guidelines and has received 510(k) clearance. It has been engineered for safety with interactive sensors to actively monitor the correct temperature to keep patients safe. Independent heating zones provide more consistent control of the warming surface.